This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Kristen Reilly
Senior Director, Strategic Insights & Access Analytics at Azurity Pharmaceuticals
Speaker

Profile

Kristen Reilly is the Senior Director of Strategic Insights & Access Analytics at Azurity Pharmaceuticals, where she leads the Global Market Research & Competitive Intelligence function and oversees pre‑ and post‑launch performance analytics across the portfolio. With more than 20 years of experience in U.S. managed markets, Kristen specializes in translating complex access dynamics, payer behavior, digital health innovations, and competitive signals into actionable commercial strategy. Her expertise sits at the intersection of analytics, value‑based care, and emerging access models. Prior to Azurity, Kristen held senior advisory roles supporting national payers, health systems, and healthcare technology organizations on market strategy and growth.

Agenda Sessions

  • Section 1: Orchestrating the Pre-Launch Symphony – Building Cross-Functional Harmony

    1:00pm

At this event